Levofolinic acid

Drug Profile

Levofolinic acid

Alternative Names: Calcium levofolinate; Calcium levoleucovorin; FUSILEV; Isovorin; Levofolinate; Levofolinate calcium; Levoleucovorin; Levoleucovorin calcium pentahydrate

Latest Information Update: 24 Mar 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Wyeth
  • Developer Spectrum Pharmaceuticals
  • Class Antidotes; Antineoplastics; Formyltetrahydrofolates; Small molecules
  • Mechanism of Action
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Colorectal cancer
  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Anaemia; Colorectal cancer; Osteosarcoma

Most Recent Events

  • 27 Oct 2016 Chemical structure information added
  • 27 Oct 2015 First generic equivalent available in USA for Osteosarcoma
  • 13 Jul 2013 Spectrum Pharmaceuticals withdraws a phase I trial prior to enrolment for Stomatitis (prevention and reduction) in patients with non-Hodgkin's lymphoma in USA (NCT01789723)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top